Literature DB >> 4032536

Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions.

C M Rice, C A Franke, J H Strauss, D E Hruby.   

Abstract

We have obtained a vaccinia virus recombinant which contains a complete cDNA copy of the 26S RNA of Sindbis virus within the thymidine kinase gene of the vaccinia virus genome. This recombinant constitutively transcribed the Sindbis sequences throughout the infectious cycle, reflecting the dual early-late vaccinia promoter used in this construction. The Sindbis-derived transcripts were translationally active, giving rise to both precursor and mature structural proteins of Sindbis virus, including the capsid protein (C), the precursor of glycoprotein E2 (PE2), and the two mature envelope glycoproteins (E1 and E2). These are the same products translated from the 26S mRNA during Sindbis infection, and thus these proteins were apparently cleaved, glycosylated, and transported in a manner analogous to that seen during authentic Sindbis infections. By using epitope-specific antibodies, it was possible to demonstrate that recombinant-derived proteins were incorporated into Sindbis virions during coinfections with monoclonal antibody-resistant Sindbis variants. These results suggest that all the information necessary to specify the proper biogenesis of Sindbis virus structural proteins resides within the 26S sequences and that vaccinia may provide an appropriate system for using DNA molecular genetic manipulations to unravel a variety of questions pertinent to RNA virus replication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4032536      PMCID: PMC252510     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Spliced early mRNAs of simian virus 40.

Authors:  A J Berk; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Two small virus-specific polypeptides are produced during infection with Sindbis virus.

Authors:  W J Welch; B M Sefton
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

3.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  In vitro transcription of the inverted terminal repetition of the vaccinia virus genome: correspondence of initiation and cap sites.

Authors:  S Venkatesan; B Moss
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

5.  Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins.

Authors:  H Garoff; A M Frischauf; K Simons; H Lehrach; H Delius
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

6.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

7.  Evidence for an autoprotease activity of sindbis virus capsid protein.

Authors:  G Aliperti; M J Schlesinger
Journal:  Virology       Date:  1978-10-15       Impact factor: 3.616

8.  Vaccinia virus replication. I. Requirement for the host-cell nucleus.

Authors:  D E Hruby; L A Guarino; J R Kates
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

9.  Detection and characterization of mouse mammary tumor virus cell surface antigens: estimation of antigen abundance by protein A assay.

Authors:  A H Callis; E M Ritzi
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

10.  Cellular differences in the molecular mechanisms of vaccinia virus host range restriction.

Authors:  D E Hruby; D L Lynn; R C Condit; J R Kates
Journal:  J Gen Virol       Date:  1980-04       Impact factor: 3.891

View more
  31 in total

1.  Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein.

Authors:  P Levy-Mintz; M Kielian
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses.

Authors:  Y S Hahn; E M Lenches; R Galler; C M Rice; J Dalrymple; J H Strauss
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Rescue of Sindbis virus-specific RNA replication and transcription by using a vaccinia virus recombinant.

Authors:  G P Li; B M Prágai; C M Rice
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Expression of the NS1 gene of dengue virus type 2 using vaccinia virus. Dimerisation of the NS1 glycoprotein.

Authors:  C R Parrish; W S Woo; P J Wright
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  A physical map of the viral genome for infectious pancreatic necrosis virus Sp: analysis of cell-free translation products derived from viral cDNA clones.

Authors:  M T Huang; D S Manning; M Warner; E B Stephens; J C Leong
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

Review 6.  Use of vaccinia virus to express biopharmaceutical products.

Authors:  D E Hruby; G Thomas
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

7.  The proteolytic cleavage of PE2 to envelope glycoprotein E2 is not strictly required for the maturation of Sindbis virus.

Authors:  J F Presely; D T Brown
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

Review 8.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

9.  Drosophila stimulatory G protein alpha subunit activates mammalian adenylyl cyclase but interacts poorly with mammalian receptors: implications for receptor-G protein interaction.

Authors:  F Quan; L Thomas; M Forte
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

10.  Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.

Authors:  R M Kinney; J J Esposito; J H Mathews; B J Johnson; J T Roehrig; A D Barrett; D W Trent
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.